We offer detection systems that allow efficient and reliable microscopic proof of antigen structures in cells and tissue sections by means of differentiated specificities and sensitivities, depending on the purpose and the method used. Our detection systems are continuously developed and improved.
Timed to the effective date of the In Vitro Diagnostics Regulation (EU) 2017/746 (IVDR) on 26.05.2022, Zytomed Systems has declared the conformity of its CE/IVD-labelled products in risk class A (e.g. detection systems) according to IVDR. Thus, these risk class A products meet all requirements of the IVDR.